Cynata Therapeutics wins US patent for stem cell technology – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics wins US patent for stem cell technology
Proactive Investors Australia Cynata's new patent covers the proprietary methods relating to the platform's ability to efficiently manufacture mesenchymal stem cells at scale. The Cymerus process includes donor screening and testing, the induced pluripotent stem cell (iPSC … |
